ClinicalTrials.gg
RecruitingNCT04550728Updated Nov 17, 2026

Hybrid Robot+FES Stroke Rehabilitation

A Phase 1/2 interventional study of Ankle robot training group and Ankle robot training and functional electrical stimulation(FES) group in Stroke, sponsored by University of Maryland, Baltimore. Recruiting at 1 site in United States. Open to participants aged 18 Years to 85 Years. Per ClinicalTrials.gov, last updated 2026-11-17.

Sponsored by University of Maryland, Baltimore · Phase 1/2, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Aug 2021; still recruiting 5 years 3 months later.
Updated Nov 17, 2026Primary completion movedStudy completion movedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 1/2
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 85 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 13 studies in Stroke by University of Maryland, Baltimore — 7 open to participants now, 7 under way, none of them phase 3. Stroke · University of Maryland, Baltimore.

Planned enrollment
4th of 11
60 · median 32
Started
2021
the only one that year
Phase 1/2
2 of 13
2 open now
Registered
7th of 13
by date

Among the 13 studies in Stroke by University of Maryland, Baltimore, this one is the 4th largest by planned enrollment of the 11 interventional ones that give a count, is the only one that started in 2021, is one of 2 in phase 1/2, and was the 7th registered.

Stroke

8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.

Browse Stroke studies →

Open to participants now

7 of the 13 studies in Stroke by University of Maryland, Baltimore are open now, in 1 country. Recruiting first, the newest first:

1 more — sign in →

By country, each count listing its studies:

All 7 open studies →

Where they have run

Who these studies take

Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.

This study: 18 Years to 85 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 13 studies in Stroke by University of Maryland, Baltimore, or all of them as a file.
02

Study summary

The investigators have developed a novel robot-guided stretching under intelligent control and combine it with active movement training, which helped increase joint ROM, reduce spasticity and joint stiffness, increase muscle force output, and improve locomotion. However, for stroke survivors with sensorimotor impairment, their peripheral muscle may not sufficiently be recruited. Functional electrical stimulation (FES), has been shown its advantage to activate the peripheral muscles for people with neurological conditions. The investigators thus make a hybrid robot-FES rehabilitation system, combining the advantage of robot and FES technologies for stroke motor recovery. The investigators further would like to translate the technologies from lab to home-based training. Thus, the investigators will conduct a randomized, controlled, primarily home-based clinical trial using an ankle robot alone or combined with functional electrical stimulation (FES) to treat sensorimotor and locomotion impairments post-stroke.

03

Conditions studied

  • Stroke

Browse trials for

Keywords

  • stroke
  • functional electrical stimulation
  • robot training
04

Who can participate

Ages eligible
18 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18-85;
  • Able to ambulate at least 10 meters without human assistance, with or without an assistive device
  • ≥ 6 months post stroke;
  • having a caregiver to assist in training at home.

Exclusion criteria

Exclusion Criteria:

  • having expressive and receptive aphasia;
  • an inability to follow multi-step commands;
  • enrolled in another lower limb rehabilitation program;
  • having severe pain in the paralyzed lower-limb;
  • >30º ankle plantar flexion contracture;
  • Having implanted electronic device such as a pacemaker, spinal cord, or deep brain stimulator because FES may potentially interfere with their functions.
05

Study design

Phase
Phase 1 / Phase 2
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    FES+robot

    Participants in this group will have FES during ankle robot training

    Combination Product: Ankle robot training and functional electrical stimulation(FES) group

  • Active comparator
    Robot

    Participants in this group will have ankle robot training only

    Combination Product: Ankle robot training group

Interventions

  • Combination productAnkle robot training group

    Patients will be seated with the paretic foot strapped to the footplate the knee at full extension. The operator will set up and measure (using the robot) ankle passive DF and PF ROM limits. The robot training will include passive stretching, robot interactive game-based training, and cool-down stretching.

  • Combination productAnkle robot training and functional electrical stimulation(FES) group

    Patients will use the ankle robot device as the ankle training group. Also, water-based FES electrodes positioned inside a soft garment will be secured over the DF and PF muscles by wrapping the garment around the leg just below the knee joint. Stimulation intensity will be increased to maximal tolerance of each participant. Electrically induced contraction timing will be triggered by the ankle robot in synchrony with the ankle dorsi and plantar flexion movements.

06

What researchers measure

Primary outcomes

  1. Fugl-Meyer Lower Extremity

    The assessment is a measure of lower extremity (LE) motor and sensory impairments post-stroke.

    Time frame: Baseline

  2. Fugl-Meyer Lower Extremity

    The assessment is a measure of lower extremity (LE) motor and sensory impairments post-stroke.

    Time frame: 6 weeks

  3. Fugl-Meyer Lower Extremity

    The assessment is a measure of lower extremity (LE) motor and sensory impairments post-stroke.

    Time frame: 12 weeks

  4. Dorsiflexion active range of motion

    Joint ankle active range of motion measured by ankle robot.

    Time frame: Baseline

  5. Dorsiflexion active range of motion

    Joint ankle active range of motion measured by ankle robot.

    Time frame: 6 weeks

  6. Dorsiflexion active range of motion

    Joint ankle active range of motion measured by ankle robot.

    Time frame: 12 weeks

  7. 6 minutes walking test

    The six-minute walk test (6MWT) measures the distance an individual is able to walk over a total of six minutes on a hard, flat surface. The goal is for the individual to walk as far as possible in six minutes.

    Time frame: Baseline

  8. 6 minutes walking test

    The six-minute walk test (6MWT) measures the distance an individual is able to walk over a total of six minutes on a hard, flat surface. The goal is for the individual to walk as far as possible in six minutes.

    Time frame: 6 weeks

  9. 6 minutes walking test

    The six-minute walk test (6MWT) measures the distance an individual is able to walk over a total of six minutes on a hard, flat surface. The goal is for the individual to walk as far as possible in six minutes.

    Time frame: 12 weeks

  10. Medical thickness of medial gastrocnemius muscle and tibial anterior muscle

    B-model ultrasound will be used to scan the muscle thickness, and the image will be further proceeded to measure the muscle thickness with unit in centimetres.

    Time frame: Baseline

  11. Medical thickness of medial gastrocnemius muscle and tibial anterior muscle

    B-model ultrasound will be used to scan the muscle thickness, and the image will be further proceeded to measure the muscle thickness with unit in centimetres.

    Time frame: 6 week

  12. Medical thickness of medial gastrocnemius muscle and tibial anterior muscle

    B-model ultrasound will be used to scan the muscle thickness, and the image will be further proceeded to measure the muscle thickness with unit in centimetres.

    Time frame: 12 week

  13. Muscle fiber pennation angle of medial gastrocnemius muscle and tibial anterior muscle

    B-model ultrasound will be used to scan the muscle and the image will be further proceeded to measure the muscle fiber pennation angle with unit in degree.

    Time frame: Baseline

  14. Muscle fiber pennation angle of medial gastrocnemius muscle and tibial anterior muscle

    B-model ultrasound will be used to scan the muscle and the image will be further proceeded to measure the muscle fiber pennation angle with unit in degree.

    Time frame: 6 week

  15. Muscle fiber pennation angle of medial gastrocnemius muscle and tibial anterior muscle

    B-model ultrasound will be used to assess the muscle thickness, muscle fiber pennation angle. Elasticity will be measured using ultrasound elastography.

    Time frame: 12 week

Secondary outcomes

  1. Timed up-to-go

    The Timed Up and Go test (TUG) is a simple test used to assess a person's mobility and requires both static and dynamic balance. It uses the time that a person takes to rise from a chair, walk three meters, turn around, walk back to the chair, and sit down.

    Time frame: Baseline

  2. Timed up-to-go

    The Timed Up and Go test (TUG) is a simple test used to assess a person's mobility and requires both static and dynamic balance. It uses the time that a person takes to rise from a chair, walk three meters, turn around, walk back to the chair, and sit down.

    Time frame: 6 weeks

  3. Timed up-to-go

    The Timed Up and Go test (TUG) is a simple test used to assess a person's mobility and requires both static and dynamic balance. It uses the time that a person takes to rise from a chair, walk three meters, turn around, walk back to the chair, and sit down.

    Time frame: 12 weeks

  4. Stroke Rehabilitation Assessment of Movement (STREAM)

    Stroke Rehabilitation Assessment of Movement Measure (STREAM) provides therapists with a quantitative measurement of motor functioning and basic mobility deficits among patients who had a stroke through the performance of 30 voluntary motor tasks of the upper extremities (UE) and lower extremities (LE).

    Time frame: baseline

  5. Stroke Rehabilitation Assessment of Movement (STREAM)

    Stroke Rehabilitation Assessment of Movement Measure (STREAM) provides therapists with a quantitative measurement of motor functioning and basic mobility deficits among patients who had a stroke through the performance of 30 voluntary motor tasks of the upper extremities (UE) and lower extremities (LE).

    Time frame: 6 weeks

  6. Stroke Rehabilitation Assessment of Movement (STREAM)

    Stroke Rehabilitation Assessment of Movement Measure (STREAM) provides therapists with a quantitative measurement of motor functioning and basic mobility deficits among patients who had a stroke through the performance of 30 voluntary motor tasks of the upper extremities (UE) and lower extremities (LE).

    Time frame: 12 weeks

  7. Brief Balance Evaluation Systems Test(Brief-BESTest)

    The Brief BESTest is a clinical balance assessment tool. It is an abbreviated version of Balance Evaluation Systems Test (BESTest), designed to assess 6 different aspects contributing to postural control in standing and walking.

    Time frame: baseline

  8. Brief Balance Evaluation Systems Test(Brief-BESTest)

    The Brief BESTest is a clinical balance assessment tool. It is an abbreviated version of Balance Evaluation Systems Test (BESTest), designed to assess 6 different aspects contributing to postural control in standing and walking.

    Time frame: 6 weeks

  9. Brief Balance Evaluation Systems Test(Brief-BESTest)

    The Brief BESTest is a clinical balance assessment tool. It is an abbreviated version of Balance Evaluation Systems Test (BESTest), designed to assess 6 different aspects contributing to postural control in standing and walking.

    Time frame: 12 weeks

  10. Modified Ashworth Scale (MAS)

    The Modified Ashworth Scale is the most widely used assessment tool to measure resistance to limb movement in a clinic setting. Scores range from 0-4, with 6 choices. 0 (0) - No increase in muscle tone; 1 (1) - Slight increase in muscle tone, manifested by a catch and release or by minimal resistance at the end of the range of motion when the affected part(s) is moved in flexion or extension; 1+ (2) - Slight increase in muscle tone, manifested by a catch, followed by minimal resistance throughout the remainder (less than half) of the range of movement (ROM); 2 (3) - More marked increase in muscle tone through most of the ROM, but affect part(s) easily moved; 3 (4) - Considerable increase in muscle tone passive, movement difficult; 4 (5) - Affected part(s) rigid in flexion or extension.

    Time frame: baseline

  11. Modified Ashworth Scale (MAS)

    The Modified Ashworth Scale is the most widely used assessment tool to measure resistance to limb movement in a clinic setting. Scores range from 0-4, with 6 choices. 0 (0) - No increase in muscle tone; 1 (1) - Slight increase in muscle tone, manifested by a catch and release or by minimal resistance at the end of the range of motion when the affected part(s) is moved in flexion or extension; 1+ (2) - Slight increase in muscle tone, manifested by a catch, followed by minimal resistance throughout the remainder (less than half) of the range of movement (ROM); 2 (3) - More marked increase in muscle tone through most of the ROM, but affect part(s) easily moved; 3 (4) - Considerable increase in muscle tone passive, movement difficult; 4 (5) - Affected part(s) rigid in flexion or extension.

    Time frame: 6 weeks

  12. Modified Ashworth Scale (MAS)

    The Modified Ashworth Scale is the most widely used assessment tool to measure resistance to limb movement in a clinic setting. Scores range from 0-4, with 6 choices. 0 (0) - No increase in muscle tone; 1 (1) - Slight increase in muscle tone, manifested by a catch and release or by minimal resistance at the end of the range of motion when the affected part(s) is moved in flexion or extension; 1+ (2) - Slight increase in muscle tone, manifested by a catch, followed by minimal resistance throughout the remainder (less than half) of the range of movement (ROM); 2 (3) - More marked increase in muscle tone through most of the ROM, but affect part(s) easily moved; 3 (4) - Considerable increase in muscle tone passive, movement difficult; 4 (5) - Affected part(s) rigid in flexion or extension.

    Time frame: 12 weeks

  13. 10-meter walk test (10MWT)

    The 10 Metre Walk Test is a performance measure used to assess walking speed in metres per second over a short distance. It can be employed to determine functional mobility, gait, and vestibular function.

    Time frame: baseline

  14. 10-meter walk test (10MWT)

    The 10 Metre Walk Test is a performance measure used to assess walking speed in metres per second over a short distance. It can be employed to determine functional mobility, gait, and vestibular function.

    Time frame: 6 weeks

  15. 10-meter walk test (10MWT)

    The 10 Metre Walk Test is a performance measure used to assess walking speed in metres per second over a short distance. It can be employed to determine functional mobility, gait, and vestibular function.

    Time frame: 12 weeks

  16. Stiffness of medial gastrocnemius muscle and tibial anterior muscle.

    Supersonic shear wave elastography will be used to estimate the shear wave speed(m/s) of the muscles.

    Time frame: Baseline

  17. Stiffness of medial gastrocnemius muscle and tibial anterior muscle.

    Supersonic shear wave elastography will be used to estimate the shear wave speed(m/s) of the muscles.

    Time frame: 6 weeks

  18. Stiffness of medial gastrocnemius muscle and tibial anterior muscle.

    Supersonic shear wave elastography will be used to estimate the shear wave speed(m/s) of the muscles.

    Time frame: 12 weeks

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Zhang LQ, Chung SG, Bai Z, Xu D, van Rey EM, Rogers MW, Johnson ME, Roth EJ. Intelligent stretching of ankle joints with contracture/spasticity. IEEE Trans Neural Syst Rehabil Eng. 2002 Sep;10(3):149-57. doi: 10.1109/TNSRE.2002.802857. PubMed 12503779 ↗
  • Selles RW, Li X, Lin F, Chung SG, Roth EJ, Zhang LQ. Feedback-controlled and programmed stretching of the ankle plantarflexors and dorsiflexors in stroke: effects of a 4-week intervention program. Arch Phys Med Rehabil. 2005 Dec;86(12):2330-6. doi: 10.1016/j.apmr.2005.07.305. PubMed 16344031 ↗
  • Ren Y, Wu YN, Yang CY, Xu T, Harvey RL, Zhang LQ. Developing a Wearable Ankle Rehabilitation Robotic Device for in-Bed Acute Stroke Rehabilitation. IEEE Trans Neural Syst Rehabil Eng. 2017 Jun;25(6):589-596. doi: 10.1109/TNSRE.2016.2584003. Epub 2016 Jun 22. PubMed 27337720 ↗
  • Embrey DG, Holtz SL, Alon G, Brandsma BA, McCoy SW. Functional electrical stimulation to dorsiflexors and plantar flexors during gait to improve walking in adults with chronic hemiplegia. Arch Phys Med Rehabil. 2010 May;91(5):687-96. doi: 10.1016/j.apmr.2009.12.024. PubMed 20434604 ↗

Individual participant data

Plan to share: No

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Aug 2021 (actual). Primary completion is estimated for Oct 2027, 74 months after the start.

Of 28 phase 1/2 interventional studies under Stroke, half reached primary completion within 39 months of starting (the median), counting those still running; a quarter within 22 and three quarters within 57. This study's planned 74 months is above that.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 17, 2026: primary completion Oct 2026 → Oct 2027 and completion Dec 2026 → Dec 2027.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Sep 3, 2020
First posted
Sep 16, 2020
StartActual
Aug 1, 2021
Primary completionEst.
Oct 1, 2027was Oct 2026
CompletionEst.
Dec 31, 2027was Dec 2026
Last update
Nov 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary completion
Oct 1, 2026→Oct 1, 2027
Nov 17, 2026
Study completion
Dec 31, 2026→Dec 31, 2027
Nov 17, 2026
Show all 1 update
  1. Nov 17, 2026
    Primary completion Oct 1, 2026→Oct 1, 2027
    Study completion Dec 31, 2026→Dec 31, 2027
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT04550728
Responsible party
Li-Qun Zhang (Professor, University of Maryland, Baltimore) — Principal investigator
First posted
Sep 16, 2020
Start date
Aug 1, 2021
Primary completion
Oct 1, 2027 (estimated)
Completion
Dec 31, 2027 (estimated)
Last update
Nov 17, 2026

Study contacts

Li-qun Zhang, PhD
Contact
L-Zhang@som.umaryland.edu
410 706 2145

Oversight

Data monitoring committee
Yes
FDA-regulated drug
Yes
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion